BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1748 related articles for article (PubMed ID: 10648030)

  • 1. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
    Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
    Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
    Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
    J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
    Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
    Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
    Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
    J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C; Sato S; Takehara K
    J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.